Small Extracellular Vesicles in the Pericardium Modulate Macrophage Immunophenotype in Coronary Artery Disease

Area of Science:

• Cardiovascular Biology
• Immunology
• Extracellular Vesicles Research

Background:

• Coronary artery disease (CAD) poses a significant global health burden.
• Pericardial macrophages play a crucial role in cardiac health and inflammation.
• Small extracellular vesicles (sEVs) are increasingly recognized as key mediators of intercellular communication in disease.

Purpose of the Study:

• To investigate the role of pericardial macrophages and sEVs in the pathogenesis of CAD.
• To identify specific molecular mechanisms by which sEVs influence macrophage function in the context of CAD.

Main Methods:

• Analysis of pericardial macrophages from CAD patients for marker expression.
• In vitro stimulation of macrophages with sEVs derived from CAD pericardial fluid.
• Characterization of sEV cargo, including microRNAs (miRNAs).
• Assessment of macrophage lipid uptake and CD36 expression.

Main Results:

• Pericardial macrophages in CAD patients exhibited reduced expression of protective markers.
• Macrophages stimulated with CAD-derived sEVs showed similar functional alterations.
• sEVs were found to contain miRNA-6516-5p.
• miRNA-6516-5p directly inhibited CD36 expression, impairing macrophage lipid metabolism.

Conclusions:

• sEV-mediated delivery of miRNA-6516-5p contributes to the reduction of protective pericardial macrophages in CAD.
• These findings highlight a novel mechanism linking sEVs, miRNAs, and macrophage dysfunction in coronary artery disease.
• Targeting sEV-miRNA pathways may offer therapeutic potential for CAD.